Image (356b3e79 D47b 467a Af62 2adca35f1a2f 01)
Tizanidine Tablet
Product Images NDC 50090-7716
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-7716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (356b3e79 D47b 467a Af62 2adca35f1a2f 02)
Image (356b3e79 D47b 467a Af62 2adca35f1a2f 03)
Image (356b3e79 D47b 467a Af62 2adca35f1a2f 04)
This text mentions an improvement in the Ashworth Score with the use of Tizanidine at a mean dose of 26.8 mg. The study involved a titration period ending at week 3, followed by a maintenance period that continued until week 7. The endpoint measurement was carried forward until the last observation in the study.*
Label Image (Lbl500907716)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
